Bio-Chips | Mysite

Biochips That Reconstruct Human Biology

CSTEAM develops advanced biochip platforms that recreate human biology in a controlled and measurable environment. By integrating microfluidics with modular biological systems, our biochips simulate interactions between tumor cells, immune components, and the microenvironment. This enables dynamic evaluation of drug response, safety, and resistance under conditions that closely reflect human physiology. Designed for scalability and reproducibility, our biochips transform complex biological processes into predictive data, supporting more accurate decision-making and reducing uncertainty in drug development.

Bio-Chips Platform

(From Molecular to Whole-Organism Chips)

Lab-on-a-Chip (LoC) Devices

Lab-on-a-Chip (LoC) has transformed diagnostics, drug discovery, environmental monitoring, and food safety with a portable, high-throughput platform. It enables rapid disease detection, efficient drug screening, real-time analysis of pollutants, and identification of contaminants, ensuring precision, cost-effectiveness, and accessibility

for a variety of applications.

Lab-on-a-chip (LoC) Devices

Diagnostic Services

Lab-on-a-chip (LoC) devices are transformative tools in diagnostic services, offering rapid, high-precision analysis with minimal sample volume. These microfluidic-based platforms integrate multiple laboratory functions, enabling real-time detection of disease biomarkers in blood, saliva, urine, and cerebrospinal fluid. LoC technology enhances early disease detection for cancer, infectious diseases, and neurodegenerative disorders by analyzing exosomal RNA, proteins, and metabolites. Their portability supports point-of-care testing (POCT), reducing reliance on centralized labs while improving accessibility in remote areas. LoC devices streamline personalized medicine, enabling tailored treatment strategies through patient-specific biomarker profiling. Their automation and scalability enhance efficiency in clinical diagnostics.

Lab-on-a-chip (LoC) Devices

Drug Discovery and Screening Services

Lab-on-a-chip (LoC) devices revolutionize drug discovery and screening by enabling high-throughput, cost-effective, and miniaturized assays. These microfluidic platforms allow precise control of cell cultures, organ-on-a-chip models, and biochemical reactions, facilitating real-time analysis of drug efficacy, toxicity, and pharmacokinetics. LoC technology accelerates target identification, lead compound screening, and personalized drug testing by integrating AI-driven automation and exosome-based biomarker analysis. Their ability to mimic in vivo conditions enhances drug candidate validation, reducing reliance on animal models. LoC devices streamline precision medicine, optimizing patient-specific responses to therapeutics and improving the efficiency of pharmaceutical R&D and clinical drug trials.

Lab-on-a-chip (LoC) Devices

Environmental Monitoring Services

Lab-on-a-chip (LoC) devices enhance environmental monitoring by providing rapid, portable, and highly sensitive detection of pollutants, pathogens, and toxins in air, water, and soil. These microfluidic platforms enable real-time analysis of heavy metals, pesticides, microplastics, and organic contaminants, minimizing reliance on traditional laboratory testing. LoC-based biosensors detect bacterial, viral, and chemical hazards, ensuring water safety, food security, and ecosystem health. Their integration with AI and IoT allows remote monitoring and data-driven decision-making. LoC technology advances climate studies, pollution control, and sustainable resource management, supporting regulatory compliance and improving global environmental protection efforts.

Lab-on-a-chip (LoC) Devices

Food Safety Services

Lab-on-a-chip (LoC) devices revolutionize food safety services by enabling rapid, on-site, and highly sensitive detection of contaminants, pathogens, and toxins in food and beverages. These microfluidic platforms identify bacteria (E. coli, Salmonella), pesticides, heavy metals, allergens, and mycotoxins in real time, reducing dependence on traditional lab-based testing. LoC biosensors enhance food quality control, supply chain monitoring, and fraud detection, ensuring compliance with safety regulations. Their automation and portability make them ideal for use in food production, distribution, and retail. By integrating AI and IoT, LoC technology improves traceability, risk assessment, and consumer health protection in the food industry.

Applications of Lab-on-a-chip (LoC) in Cell-Derived Exosome Research and Diagnostics

Lab-on-a-chip (LoC) technology has revolutionized exosome research by enabling highly efficient isolation, characterization, biomarker detection, and drug delivery, while also advancing personalized medicine. By integrating nanotechnology and microfluidics, LoC devices enhance precision, scalability, and real-time analysis in biomedical diagnostics and therapeutics. These innovations facilitate rapid, high-throughput screening of exosomal RNA, proteins, and lipids, significantly improving disease detection, prognosis, and targeted therapy. Additionally, LoC-based biochips optimize exosome engineering for applications in drug delivery, gene therapy, and regenerative medicine. CSTEAM Biotechnology has developed state-of-the-art LoC technology specifically designed for exosome research, driving breakthroughs in liquid biopsy, neurodegenerative disease diagnostics, and next-generation therapeutic strategies, ultimately enhancing clinical and translational medicine.

Exosome Isolation and Purification

Microfluidic-Based Separation: LoC devices allow rapid, high-purity exosome isolation using size-exclusion, immunoaffinity capture, and dielectrophoresis.
Nanomaterial-Enhanced Capture: Gold nanoparticles, magnetic beads, and graphene-based biochips improve exosome recovery and specificity.
Advantages: Faster, more scalable, and requires less sample volume compared to ultracentrifugation or precipitation methods.

Exosome Characterization and Quantification

Lab-on-a-Chip Biosensors: Detect exosomal markers (CD9, CD63, CD81) using electrochemical, optical, or plasmonic sensors.
Size and Morphology Analysis: LoC devices integrate nanoplasmonic and microfluidic imaging for high-resolution exosome profiling.
Advantages: Enables real-time, label-free exosome analysis with high sensitivity.

Exosome-Based Biomarker Detection for Disease Diagnostics

Cancer Detection: LoC platforms detect tumor-derived exosomal RNA, proteins, and metabolites in liquid biopsy applications.
Neurodegenerative Disease Monitoring: Detects exosomal biomarkers from cerebrospinal fluid (CSF) for Alzheimer’s, Parkinson’s, and ALS.
Infectious Disease Screening: Identifies viral RNA/proteins in exosomes for early detection of COVID-19, HIV, and bacterial infections.
Advantages: Non-invasive, high-throughput, and cost-effective early disease detection.

Exosome Engineering for Drug Delivery and Gene Therapy

On-Chip Exosome Loading: LoC devices facilitate exosome modification with therapeutic molecules, such as siRNA, mRNA, or CRISPR/Cas9 components.
Targeted Delivery Enhancement: Functionalized exosomes improve precision drug delivery to specific tissues or tumors.
Advantages: Efficient, scalable, and maintains exosome integrity for controlled drug release.

Personalized Medicine and Real-Time Disease Monitoring

Patient-Specific Exosomal Profiling: LoC technology enables personalized treatment based on exosomal RNA/protein signatures.
Point-of-Care Testing (POCT): Portable LoC devices allow real-time, bedside exosome diagnostics for cancer, cardiovascular diseases, and inflammatory conditions.
Advantages: Enables precision medicine, faster diagnosis, and real-time monitoring of therapy response.

Regenerative Medicine and Stem Cell Therapy

Stem Cell-Derived Exosomes: LoC-based screening enhances the therapeutic potential of exosomes in wound healing, neuroprotection, and cardiac repair.
Organ-on-a-Chip Models: Simulates tissue environments to study exosome interactions in regenerative medicine.
Advantages: Accelerates stem cell therapy development while reducing animal testing requirements.